PLAAT4 Gene (Phospholipase A and Acyltransferase 4)

Comprehensive genomic and functional analysis of PLAAT4, a tumor suppressor and phospholipid-modifying enzyme.

Gene Information Card

Symbol PLAAT4
Full Name Phospholipase A and Acyltransferase 4
Gene Type Protein coding
Chromosomal Location 1q32.1
NCBI Gene ID 10979 ncbi.nlm.nih.gov/gene/10979
Ensembl ID ENSG00000143157
UniProt ID Q9H0J9
OMIM ID 607673
HGNC ID 5171
Aliases HRASLS4, H-REV107-1, HREV107, HRAS-like suppressor 4

Description

PLAAT4 (Phospholipase A and Acyltransferase 4) is a protein-coding gene located on chromosome 1q32.1. It encodes a member of the PLAAT family, which possesses both phospholipase A1/A2 and acyltransferase activities. PLAAT4 is known as a tumor suppressor, originally identified as a HRAS-like suppressor (H-REV107). It is involved in phospholipid metabolism, regulation of cell proliferation, and apoptosis. The gene is frequently downregulated in various cancers, and its loss contributes to tumorigenesis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Lung cancer Loss of PLAAT4 expression leads to increased cell proliferation and resistance to apoptosis; acts as a tumor suppressor via HRAS pathway inhibition. PMID: 10652317; COSMIC database
Colorectal cancer Reduced PLAAT4 expression correlates with poor prognosis; epigenetic silencing observed. PMID: 15604238; ClinVar
Breast cancer PLAAT4 downregulation associated with aggressive tumor phenotypes and metastasis. PMID: 17563756; COSMIC
Ovarian cancer Methylation-mediated silencing of PLAAT4 contributes to oncogenesis. PMID: 18367542

Expression Profile

Tissue Expression
Tissue nTPM level
Adipose tissue 0.8 Low
Lung 2.1 Medium
Colon 1.5 Low
Breast 1.2 Low
Ovary 1.0 Low
Testis 3.4 Medium
Brain 0.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
A549 (lung cancer) 0.9 Low expression; consistent with tumor suppressor role
HCT116 (colorectal cancer) 1.1 Reduced compared to normal colon
MCF7 (breast cancer) 0.7 Downregulated
HeLa (cervical cancer) 1.3 Moderate expression
HEK293 (embryonic kidney) 2.5 Baseline expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense <0.1% Likely loss of start codon; loss of function
c.214C>T (p.Arg72Trp) Missense <0.1% Unknown significance; reported in COSMIC
c.337G>A (p.Gly113Ser) Missense <0.1% Unknown significance
c.454_455insA Frameshift <0.1% Predicted loss of function
c.562C>T (p.Arg188*) Nonsense <0.1% Premature stop; loss of function
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations (e.g., c.454_455insA, c.562C>T) are predicted to cause loss of function, consistent with PLAAT4's tumor suppressor role.

Gain of Function (GOF)

No gain-of-function mutations have been reported in PLAAT4.

Dominant Negative (DN)

No dominant-negative mutations have been described for PLAAT4.

Pathways

• Phospholipid metabolism
• HRAS signaling pathway (negative regulation)
• Apoptosis signaling

Protein Summary

The PLAAT4 protein (UniProt Q9H0J9) is a 189-amino acid enzyme with dual phospholipase A1/A2 and acyltransferase activities. It localizes to the cytoplasm and is involved in phospholipid remodeling. PLAAT4 acts as a tumor suppressor by inhibiting HRAS-mediated signaling and promoting apoptosis. Its expression is frequently lost in cancers due to promoter methylation or deletion.

Related Products

Product name Cat.No. Species Gene ID
PLAAT4 Knockout HEK293 Cell Line EDJ-KQ2046 Human 5920 Details Get a Quote
PLAAT4 Knockout A-549 Cell Line EDJ-KQ22099 Human 5920 Details Get a Quote
PLAAT4 Knockout HeLa Cell Line EDJ-KQ22100 Human 5920 Details Get a Quote
PLAAT4 Knockout HCT 116 Cell Line EDJ-KQ77882 Human 5920 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: